Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T15:42:17.739Z.
Consensus retrieved: 2026-10-06T12:42:06.679Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T15:42:17.739Z.
Quote observation: 2026-10-06T15:40:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 84f755396c9cc6b6c9535f897ba0f48fef5a33e79b5fb4c136097311f2feddf3
FORWARD PE RATIO
N/A
IM Cannabis Corp.
Market Cap
$1.15M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| IM Cannabis Corp. (IMCC) | $1.15M | N/A |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.17M | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.20M | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.04M | N/A |
| Genprex, Inc. (GNPX)vs › | $1.36M | N/A |
| NewcelX Ltd. (NCEL)vs › | $1.36M | N/A |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.38M | N/A |
| NEXGEL, Inc. (NXGL)vs › | $1.40M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
Consensus estimates for this stock are reported in CAD, while the share price trades in USD — so per-fiscal-year implied multiples can't be computed honestly here. The analyst estimates table shows the consensus figures with their correct currency label.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
